Medical AI provider Lunit raises $61m in pre-IPO fundraising round
Healthcare growth equity firm HealthQuest Capital has provided $20m of the total amount.

Healthcare growth equity firm HealthQuest Capital has provided $20m of the total amount.
LumiraDx has ten new tests awaiting approvals over the next two years as well as five already approved assays.
The deal will make Baxter one of the leaders in the connected devices market and expand its digital health offerings.
ByThe proceeds will be used to enhance the Breath Biopsy platform and commercialise certain tests.
The technology will be used to identify and grade cancer in prostate biopsies from samples of 600 men across 14…
Smart hospitals and their state-of-the-art technology are promising and require additional investment and organisation.
ByMedical device company CartiHeal developed the Agili-C implant for treating cartilage and osteochondral defects.
On closing the deal, current LumiraDx stakeholders will retain the entirety of their present holdings in the company.
Thank you for subscribing to Medical Device Network